15-Nov-2024	Investor presentation, 15 November 2024

7-Oct-2024	Investor webinar: Neuren continues PMS Phase 3 preparations following positive FDA meeting

19-Aug-2024	Investor roadshow presentation, 19 August 2024

9-Aug-2024	Investor webinar: NNZ-2591 Angelman syndrome Phase 2 trial top-line results

9-Aug-2024	NNZ-2591 Angelman top-line results presentation

29-May-2024	Corporate Presentation, 29 May 2024

28-May-2024	AGM webcast, 28 May 2024

28-May-2024	AGM Chair Address & CEO Presentation

27-May-2024	Investor webinar - Pitt Hopkins Phase 2 results, 27 May 2024

27-May-2024	Pitt Hopkins Phase 2 results presentation, 27 May 2024

15-May-2024	Investor presentation, 15 May 2024

1-Mar-2024	Investor webinar, 29 February 2024

18-Dec-2023	Investor web conference, 18 December 2023

18-Dec-2023	Investor presentation, 18 December 2023

8-Nov-2023	Investor presentation, 8 November 2023

29-Aug-2023	Investor web conference, 28 August 2023

28-Aug-2023	Investor presentation, 28 August 2023

14-Jul-2023	Investor web conference, 14 July 2023

5-Jun-2023	Jefferies Global Healthcare Conference, 8 June 2023

2-Jun-2023	AGM webcast, 30 May 2023

30-May-2023	AGM Chair Address & CEO Presentation

17-Mar-2023	Investor webinar, 14 March 2023

7-Dec-2022	MST Financial: Late Stage Biotech Forum, 30 Nov 2022

29-Nov-2022	Bell Potter Healthcare Conference, 8 Nov 2022

30-May-2022	AGM Chairman's Address & CEO Presentation

25-Feb-2022	Investor webinar, 25 February 2022

29-Jun-2021	MST Access Australian Micro & Small Caps Conference 2021 15 June 2021